Top Markets
Coin of the day
LadRx Corporation LadRx Corporation

LadRx Corporation

LADX
주식 순위 #42092
LadRx Corporation, a biopharmaceutical company, engages in research and... LadRx Corporation, a biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States. The company offers linker activated drug releases (LADR) technology, a platform consists of an organic backbone that is attached to a chemotoxic agent that targets and delivers the chemotoxic agent to the tumor environment and release within the tumor. Its lead candidates comprising LADRs 7, 8, 9, and 10 with novel derivatives of the auristatin and maytansinoid drug targeting tumors; and aldoxorubicin, which is in phase II clinical development for the treatment of pancreatic cancer. In addition, the company develops albumin companion diagnostic (ACDx) to identify patients with cancer that benefits from treatment with the four LADR lead candidates. The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. The company was incorporated in 1985 and is headquartered in Los Angeles, California.
주가
$0.01
마지막 동기화: 2026-07-20
시가총액
$4.95K
변동 (1일)
0.00%
변동 (1년)
-98.46%
국가
US
거래 LadRx Corporation (LADX)

카테고리

LadRx Corporation (LADX)의 수익
2026 기준 수익 TTM: 0
LadRx Corporation의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
LadRx Corporation의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
$5.27B -
US
$1.95B -
NL
- -
CH
$3.01B -
BE
- -
KR